Back to Search Start Over

Protein Phosphatase 1 Regulatory Subunit SDS22 Inhibits Breast Cancer Cell Tumorigenesis by Functioning as a Negative Regulator of the AKT Signaling Pathway123

Authors :
Paul, Debasish
Bargale, Anil Bapu
Rapole, Srikanth
Shetty, Praveen Kumar
Santra, Manas Kumar
Source :
Neoplasia (New York, N.Y.)
Publication Year :
2018
Publisher :
Neoplasia Press, 2018.

Abstract

Protein phosphatases play a crucial role in cell cycle progression, cell survival, cellular signaling, and genomic integrity. The protein phosphatase 1 (PP1) regulatory subunit SDS22 plays a significant role in cell cycle progression. A recent study showed that SDS22 plays a vital role in epithelial integrity and tumor suppression in Drosophila. However, its tumor suppressive activity remains obscure in the mammalian system. Here, for the first time, we show that SDS22 inhibits the growth of breast cancer cells through induction of apoptosis. SDS22 negatively regulates the AKT kinase signaling pathway through PP1. SDS22 associates predominantly with AKT and dephosphorylates the phospho Thr308 and phospho Ser473 through PP1 and hence abrogates the cell migration, invasion, and tumor growth. Thus, our study deciphers the long-standing question of how PP1 negatively regulates the AKT signaling pathway. Further, we observed a significant converse correlation in the expression levels of SDS22 and phospho form of AKT with reduced levels of SDS22 in the higher grades of cancer. Overall, our results suggest that SDS22 could be a putative tumor suppressor and replenishment of SDS22 would be an important strategy to restrict the tumor progression.

Subjects

Subjects :
EMT, Epithelial to mesenchymal transition
GFP, Green fluroscent protein
Bcl2, B cell leukemia/lymphoma 2
SDS, Sodium dodecyl sulphate
Gene Expression
Apoptosis
PP2, Protein phosphatase 2
FOXO1, Forkhead box O1
Mice
Cell Movement
Protein Phosphatase 1
MEK, Mitogen-activated protein kinase
MAPK, Mitogen activated protein kinase
IKK, inhibitor of nuclear factor kappa B kinase
RPMI, Roswell Park Memorial Institute
ERK, Mitogen-activated protein kinase 1
DMEM, Dulbecco's modified Eagle's medium
FACS, Fluorescence activated cell sorting
SDS22, Protein phosphatise regulatory subunit 7 or PPP1R7
AKT, AKT serine/threonine kinase/ Protein kinase B
PBS, Phosphate buffer saline
qRT-PCR, quantitative real-time PCR
PVDF, Polyvinylidenedifluoride
eIF4E, eukaryotic translation initiation factor 4E
mTOR, mechanistic target of rapamycin kinase
BAX, BCL2-associated X protein
Cell Transformation, Neoplastic
BAD, BCL2 associated agonist of cell death
Heterografts
Female
TNBC, Triple negative breast cancer
Signal Transduction
Original article
Epithelial-Mesenchymal Transition
MAP Kinase Signaling System
PAGE, Polyacrylamide gel electrophoresis
GSK3β, Glycogen synthase kinase 3 beta
Breast Neoplasms
PARP1, poly(ADP-ribose) polymerase 1
Models, Biological
PHLPP1, PH domain and leucine rich repeat protein phosphatase 1
BSA, Bovine serum albumin
Cell Line, Tumor
PDK1, pyruvate dehydrogenase kinase 1
Animals
Humans
FBS, Foetal bovine serum
UK, United kingdom
JNK, c-Jun NH2-terminal kinase
SHIP, inositol polyphosphate-5-phosphatase D
Cell Proliferation
Neoplasm Staging
PP1, Protein phosphatase 1
PTEN, phosphatase and tensin homolog
PUMA, BCL2 binding component 3
USA, United states of America
Disease Models, Animal
APAF1, apoptotic peptidase activating factor 1
NOD-SCID mice, Non obese diabetic -everely compromised immune deficient mice
Neoplasm Grading
Proto-Oncogene Proteins c-akt

Details

Language :
English
ISSN :
14765586 and 15228002
Volume :
21
Issue :
1
Database :
OpenAIRE
Journal :
Neoplasia (New York, N.Y.)
Accession number :
edsair.pmid..........b891d93bddfb4a69fff82d29bb6cf4ff